In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Boehringer Ingelheim

236 results for your search

Advances in anticoagulation: balancing safety and efficacy.

Event : ESC Congress 2020

  • Session : Atrial fibrillation patients in focus: clinical cases and guidelines
  • Speaker : GYH Lip (Liverpool,GB)
  • Sponsored by Boehringer Ingelheim

Anticoagulation and comorbidities.

Event : ESC Congress 2020

  • Session : Atrial fibrillation patients in focus: clinical cases and guidelines
  • Speaker : C Ruff (Boston,US)
  • Sponsored by Boehringer Ingelheim

Antithrombotic therapy post-PCI: applying evidence from RE-DUAL PCI to challenging cases.

Event : ESC Congress 2020

  • Session : NOACs in patients with atrial fibrillation: insights from the cardiac cath lab
  • Speaker : J ten Berg (Nieuwegein,NL)
  • Sponsored by Boehringer Ingelheim

Atrial Fibrillation management: from clinical evidence to real world practice

Event : ESC Asia 2020

  • Session : Atrial Fibrillation (AF) Management: from clinical evidence to real world practice
  • Speaker : GYH Lip (Liverpool,GB)
  • Sponsored by Boehringer Ingelheim

Atrial fibrillation patients in focus: clinical cases and guidelines: Introduction.

Event : ESC Congress 2020

  • Session : Atrial fibrillation patients in focus: clinical cases and guidelines
  • Speaker : E Hylek (Boston,US)
  • Sponsored by Boehringer Ingelheim

Atrial fibrillation patients in focus: clinical cases and guidelines: Q&A.

Event : ESC Congress 2020

  • Session : Atrial fibrillation patients in focus: clinical cases and guidelines
  • Sponsored by Boehringer Ingelheim

Cardiologist Taking the Lead – Practical Initiation and Management

Event : ESC Congress 2020

  • Session : Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors
  • Speaker : S Anker (Berlin,DE)
  • Organised by Radcliffe Medical Education, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?

Event : ESC Asia 2020

  • Session : What have we learned from SGLT-2 inhibitors in heart failure?
  • Speaker : SM Kang (Seoul,KR)
  • Sponsored by Boehringer Ingelheim

Dual versus triple therapy after percutaneous coronary intervention.

Event : ESC Congress 2020

  • Session : Atrial fibrillation patients in focus: clinical cases and guidelines
  • Speaker : J Steffel (Zurich,CH)
  • Sponsored by Boehringer Ingelheim

Finding order in complexity: dual versus triple antithrombotic therapy post-PCI.

Event : ESC Congress 2020

  • Session : NOACs in patients with atrial fibrillation: insights from the cardiac cath lab
  • Speaker : DJ Angiolillo (Jacksonville,US)
  • Sponsored by Boehringer Ingelheim

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are